University Of Tartu

Cardiovascular disease prevention

Research activity includes coronary artery disease risk stratification using polygenic risk scores, with a focus on identifying individuals at elevated inherited risk for future cardiovascular events and mortality.

  • High polygenic risk for coronary artery disease
  • Cardiovascular event prevention
  • Risk-based statin therapy

The sponsor’s work in this area centers on translating genetic risk information into preventive lipid-lowering therapy for cardiovascular protection.

Perioperative symptom control

Another area of interest is the prevention of postoperative nausea and vomiting, particularly in the context of bariatric surgery, where symptom burden can affect postoperative recovery and comfort.

  • Postoperative nausea and vomiting
  • Bariatric surgery
  • Antiemetic therapy

This therapeutic focus reflects involvement in perioperative care aimed at reducing common surgical complications.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Semaglutide and Granisetron for Tolerability in Overweight Adults Without Diabetes

    Not yet recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Estonia
  • Study on Rosuvastatin and Atorvastatin for Preventing Heart Disease in Patients with High Genetic Risk

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Estonia
  • Study on Aprepitant for Preventing Nausea and Vomiting After Bariatric Surgery in Patients

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Estonia